List of Posters

Posters on Main Workshop Day1 (Tuesday September 27, 2022)

Immunogenicity, Biomarkers, Ligand-Binding PK Assays

Day1-P01: "Development and validation of a specific and sensitive method for detection of anti-tocilizumab antibodies in human serum in presence of high concentrations of drug and target."
Poster Presenter: Kamala Bhavaraju (Dr. Reddy's Laboratories Ltd., Hyderabad, Other/None, India)
Co-Authors: Mamta Kumari Dhiman1, Sagarika Sunil Gadgil1, Hema Desai2, Kyla O’Brien2, Chris Beaver2 and Vikas Kumar1
1Biologics, Dr. Reddy’s Laboratories Ltd. Bachupally, Hyderabad 500090, Telangana, India. 2Syneos Health 301D College Road East Princeton, NJ 08540, USA.
Day1-P02: "Development of a machine learning model for guiding the development of anti-drug antibody assays"
Poster Presenter: Chong Kim (AstraZeneca, Gaithersburg, Maryland, United States)
Co-Authors: Chong Kim1, Olga Obrezanova2, Bjarki Johannesson3, Sarah Kerscher1, Karl Navarro1, Animesh Shukla1, Varghese Abraham1, Ali Sedaghatpour1, Ankur Patel1, Mishal Patel2 , Weiping Shao1
1Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gaithersburg, USA 2Imaging and Data Analytics, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, UK 3Imaging and Data Analytics, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden
Day1-P03: "Genentech Bioanalytical ADA Method Comparability: Technical and Clinical Strategies "
Poster Presenter: Ihsan Nijem (Genentech, South San Francisco, California, United States)
Co-Authors: R. Elliott, W. Yan, T. Pourmohamad, Y. Webb Vargas, M. Maia, J. Zanghi, Y. Song
Genentech (A Member of the Roche Group)
Day1-P04: "Application of a Single Cemiplimab ADA Screening Cut Point Factor Across Different Oncology Disease Indications"
Poster Presenter: Andrew Dengler (Regeneron, Tarrytown, New York, United States)
Co-Authors: Jenny L. Valentine, Andrew Dengler, An Zhao, Tiffany Truong, Jacqueline Rodriguez, Sean McAfee, Mohamed Hassanein, Anne Paccaly, Susan C. Irvin, Jihua Chen, Albert Torri, Giane Sumner, Matthew D. Andisik, Michael A. Partridge
Regeneron Pharmaceuticals, 777 Old Saw Mill River Rd, Tarrytown, NY, 10591, USA
Day1-P05: "Mitigation of the presence of crosstalk in an ADA bridging assay using the MSD platform"
Poster Presenter: Mathilde Yu (CIRION BioPharma Inc., Laval, Quebec, Canada)
Co-Authors: Sylvie Gélinas, Martin Roberge, Justine Bélanger, Chrystel Bertheau, Nancy Petitclerc, André Forté, Mathilde Yu
CIRION BioPharma Inc.
Day1-P06: "Development of a Bridging ECL Method for the Detection of Anti-Drug Antibodies in Human Serum on an Automated System."
Poster Presenter: Danielle Marshall (Teva Pharmaceuticals, West Chester, Pennsylvania, United States)
Co-Authors: Jon Goodwin, Mary Belfast, Hetal Sojitra
Teva Pharmaceuticals
Day1-P07: "Overcoming Non-clinical Anti-Drug Antibody Assay Development Challenges for a Peptide Therapeutic"
Poster Presenter: Helen Davis (Genentech, South SF, California, United States)
Co-Authors: Helen Davis, Suk Hyung, Mehraban Khosraviani, and Ola M. Saad
Genentech
Day1-P08: "Development of PK and ADA methods for trispecific antibody: comparison of technologies and optimization."
Poster Presenter: Magali Carcenac (sanofi, Montpellier, Other/None, France)
Co-Authors: Patrick Vergès, Corinne Thomas-Bourès, Nicolas Brémond, Emma Riberolle, Magali Carcenac, Eric Guillemare, Laurent Vermet and Olivier Fedeli; Sanofi R&D, TMED-BCB, Biological Analyses, Montpellier, France.
Sanofi
Day1-P09: "Identification of Proteins in Human Serum that Interfere in ELISA-Based PK and Biomarker Assays"
Poster Presenter: Shawn Li (Teva Branded Pharmaceutical Products R&D, Inc, West Chester, Pennsylvania, United States)
Co-Authors: Jenny E. Morgan, Amrutha Murthy, Eilam Doron, and Michele Rasamoelisolo
Teva Branded Pharmaceutical Products R&D, Inc
Day1-P10: "Validation of a novel, Fit-for-purpose Simple Western method for Biomarker assessment in Tissues"
Poster Presenter: Pratiksha Gulati (Roche, Basel, Other/None, Switzerland)
Co-Authors: Pratiksha Gulati
Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland
Day1-P11: "CATHEPSIN G, IDENTIFYING, OPTIMIZING AND IMPLAMENTING A COMMERCIAL ELISA KIT FOR CLINICAL USE "
Poster Presenter: Fizal Nabbie (BMS, Princeton, New Jersey, United States)
Co-Authors: Linh Ma, Peter Schafer, Jessica Landis, Teja Yarra and Graham Yearwood
Bristol Myers Squibb, Princeton, NJ 08543 U.S.A.
Day1-P12: "Comparison of Three Ultra-sensitivity IL-17F Assay in Human Serum"
Poster Presenter: Rong Liu (Bristol-Myers Squibb Company, Princeton, New Jersey, United States)
Co-Authors: Yi Luo, Ian Catlett, Andrew Jadwin, Jianing Zeng
Bristol-Myers Squibb Company
Day1-P13: "Development of a new lysine conjugation process in DMPK based on the investigation of Anti-BI A00000 conjugation results to improve assay performance"
Poster Presenter: Hamid Samareh Afsari (Boehringer Ingelheim, Ridgefield, Connecticut, United States)
Co-Authors: Hamid Samareh Afsari, Andrey Konovalov, Luda Zaslavskaia, Jhanelle Glasford, Tammy Bigwarfe, Emily Werth, Shan Jiang, Kelly Coble, Adam Vigil and Elisa Oquendo Cifuentes
Boehringer Ingelheim
Day1-P14: "Mini-Dystrophin/Dystrophin Biomarker assay development for DMD clinical trial support"
Poster Presenter: Yong Zhuang (BMS, Lawrence, New Jersey, United States)
Co-Authors:
Day1-P15: "Implementation of Automated Sample Dilution Utilizing Hamilton Vantage Automated Liquid Handler to Support the Pharmacokinetic Assay of TEV-48125 Phase 3 Clinical Studies "
Poster Presenter: Xiaofeng Lu (Teva Branded Pharmaceutical Products R&D, Inc, West Chester, Pennsylvania, United States)
Co-Authors: Mary Belfast, Hongzhe Wang, Alex Kogan, Shawn Li, and Michele Rasamoelisolo
Teva Branded Pharmaceutical Products R&D, Inc
Day1-P16: "Overcoming matrix interference and increasing assay sensitivity by optimizing sample treatment"
Poster Presenter: Sally Ye (Boehringer Ingelheim, Ridgefield, Connecticut, United States)
Co-Authors: Corina Place, Daniel Kim, Kelly Coble
Boehringer Ingelheim
Day1-P17: "Qualification of a Luciferase Reporter Gene Assay to Measure Neutralizing Antibody Titers to Engineered Vaccinia Virus"
Poster Presenter: Shuo Tang (Astra Zeneca, Gaithersburg, Maryland, United States)
Co-Authors: Shuo Tang(1), Surekha Krishnan(1), Indiwari Gopallawa(1), Jessica Wang(2), Zhongying Chen(2), Jason Laliberte(3), Weiping Shao(1)
(1) Integrated Bioanalysis, Clinical Pharmacology and Safety Sciences, GxP Testing Laboratories, AstraZeneca, Gaithersburg, United States (2) Discovery Bioanalysis, Integrated Bioanalysis, Clinical Pharmacology and Safety Sciences, AstraZeneca, Gaithersburg, United states (3) Virology and Vaccine Discovery, AstraZeneca, Gaithersburg, United States
Day1-P18: "Bioanalytic Support for the Development of Oncolytic Virus Products"
Poster Presenter: Zhongying Chen (Astrazeneca, Gaithersburg, Maryland, United States)
Co-Authors: Hui Liu
AstraZeneca
Posters on Main Workshop Day2 (Wednesday September 28, 2022)

Vaccine, Gene Therapy, EliSpot, qPCR, NGS, Flow

Day2-P01: "SARS-CoV-2 Receptor (ACE2) Inhibition Assay: A Rapid High Throughput Assay Useful for Vaccine Immunogenicity Evaluation "
Poster Presenter: Joyce Plested (Novavax Inc., Gaithersburg, Maryland, United States)
Co-Authors: Joyce S. Plested, Raj Kalkeri, Mingzhu Zhu, Shane Cloney-Clark, Ed Massuda, Urvashi Patel, Andrew Klindworth, Michael Massare, Rongman Cai, Lou Fries, Greg Glenn
Novavax Inc, Gaithersburg, MD.
Day2-P02: "Assessment of immunogenicity in SARS-CoV-2 naïve and convalescent subjects following COVID-19 vaccination"
Poster Presenter: Hua-Chen Chang (Labcorp Drug Development, Indianapolis, Indiana, United States)
Co-Authors: Ning Li (1), Dana Davis (1), Brian Getman (1), Karlesa Johnson (1), Chase Jones (1), Tamika Meredith (1), Terri Wrin (2), Christos Petropoulos (2), and Pritty Patel (1)
(1) Vaccines & Novel Immunotherapeutics, Labcorp Central Laboratory Services, Indianapolis IN, USA; (2) Monogram Biosciences, Labcorp Specialty Testing Group, San Francisco, CA, USA
Day2-P03: "Development and Validation of multi-species quantitative anti-protective antigen IgG ELISA for analysis of pre-clinical trial for Anthrax vaccine"
Poster Presenter: Ara Kim (GC Biopharma, Gyeonggi-do , Other/None, Korea, Republic of)
Co-Authors: Heewon Jeong
Day2-P04: "Pseudovirus based Neutralization Assay for SARS-CoV-2 Variants: A Rapid cost-effective BSL2 based High Throughput Assay Useful for Vaccine Immunogenicity Evaluation "
Poster Presenter: Raj Kalkeri (Novavax, Gaithersburg, Maryland, United States)
Co-Authors: Zhaohui Cai, Raj Kalkeri, Mingzhu Zhu, Shane Cloney-Clark, Mi Wang, Zach Longacre, Michael Massare, Greg Glenn, Joyce S. Plested
Novavax, Gaithersburg, MD.
Day2-P05: "Development of Immunogenicity Assays to Detect anti-AAV9 Immune Response in Pre-Clinical and Clinical Studies"
Poster Presenter: Kristen Gaffney (Charles River Laboratories, Mattawan, Michigan, United States)
Co-Authors: Leslie Kuiper, Rachel Sterling, Michael Benson, Jessica St. Charles, Jeffrey Haskins
Charles River Laboratories
Day2-P06: "Assessing Immunogenicity for Expressed Biologics in Gene Therapy"
Poster Presenter: Zhe Wang (AstraZeneca, BOYDS, Maryland, United States)
Co-Authors: Animesh Shukla, Ankur Patel, Surekha Krishnan, Nichelle West, Jonathan Hirsch, Weiping Shao
AstraZeneca
Day2-P07: "Qualification of a Cynomolgus Monkey anti-AAV8 Total Antibody Assay and Concordance with a Cell-Based Transduction Inhibition Assay."
Poster Presenter: Mikayla Higgins (REGENXBIO, Inc., Rockville, Maryland, United States)
Co-Authors: Mikayla Higgins; Hiren Patel; Aaron Kopen; Svetlana Filippova; Louis Gardner; Kelly Snyder; Michele Fiscella; Lin Yang.
REGENXBIO Inc, Rockville, MD 20850
Day2-P08: "Optimization of Sample Collection and Development Procedures for Nonhuman Primate IFNγ ELISpot"
Poster Presenter: Bryan Simons (Labcorp Early Development Laboratories, Madison, Wisconsin, United States)
Co-Authors: Authors: Bryan Simons, J. Scott Fites, and Amanda Lucchini
All Authors - Labcorp Early Development Laboratories Inc., Immunology & Immunotoxicology Dept., Madison, WI
Day2-P09: "Optimization and standardization of RNA-seq operation to get high-quality sequencing data with heavily degraded RNA samples from tumor biopsies"
Poster Presenter: Yixiao Cui (Frontage Laboratories, Inc., Exton, Pennsylvania, United States)
Co-Authors: Chen Chen, Bin Xu
Frontage Laboratories, Inc.
Day2-P10: "Qualification and comparability of ddPCR to qPCR assays for AAV gene therapy biodistribution"
Poster Presenter: Jeremiah Hendricks (Prevail Therapeutics, New York, New York, United States)
Co-Authors: Jeremiah Hendricks, Carter Daniels, Michael Banjoko, Sid Kamalakaran, Li Chin Wong
Prevail Therapeutics
Day2-P11: "Qualification of a Real-time qPCR method to quantify oncolytic Vaccinia Virus genome copies in DNA samples extracted from non-human primate (NHP) matrices"
Poster Presenter: Amin Eimanifar (AstraZeneca, Gaithersburg, Maryland, United States)
Co-Authors: 1Amin Eimanifar, 1Sarah Kerscher, 1Rachel Schiffenbauer, 2Zhongying Chen and 1Weiping Shao
1GxP Testing Laboratories, 2Discovery Bioanalysis, Integrated Bioanalysis, AstraZeneca, Gaithersburg, MD
Day2-P12: "A Universal Approach for Generation of Robust CAR-agnostic Calibrators for qPCR Quantification"
Poster Presenter: Nathan Riccitelli (Navigate BioPharma, Carlsbad, California, United States)
Co-Authors: Sarah Heine, Olivia Sclafani, Kevin Lee, Ashley Beams, Sridevi Kayyur Subramanya, Nathan Riccitelli
Navigate Biopharma Services Inc., a Novartis subsidiary
Day2-P13: "Using Droplet Digital PCR to identify and quantify point mutations in circulating tumour DNA in a clinical trials setting."
Poster Presenter: Kurt Sales (Agilex Biolabs, Adelaide, Other/None, Australia)
Co-Authors: Kurt Sales; Asiri Wijenayaka; Patrick Hughes; Marc Fiorucci
Agilex Biolabs Pty Ltd
Day2-P14: "Novel Methods Validated for Pharmacokinetic and Hematological Monitoring on Small Volume Blood from Gene or Cell Therapies"
Poster Presenter: Bin Xu (Frontage Laboratories, Exton, Pennsylvania, United States)
Co-Authors: Ryan Haley
Frontage Laboratories
Day2-P15: "RT-qPCR methods to support siRNA drugs analysis"
Poster Presenter: Bo Wei (WuXi AppTec (Suzhou) Co., Ltd., Suzhou, Other/None, China)
Co-Authors: Bo Wei, Hua Yang, Zheng Wei, Yonghui Wang, Bo Li, Xiaoying Jin, Jing Shi
WuXi AppTec, Inc., 1336 WuZhong Avenue, Suzhou, Jiangsu, China
Day2-P16: "Forward Primer Modification to Detect 5’ Deaminated siRNA Metabolites by RT-qPCR"
Poster Presenter: Justin Darcy (Alnylam Pharmaceuticals, Cambridge, Massachusetts, United States)
Co-Authors: Lawrence Ma, Holly Lindgren, and Sarah Bond
Alnylam Pharmaceuticals, Bioanalytical Sciences, 675 West Kendall Street, Cambridge, MA 02142
Day2-P17: "Development of a multiplex RT-qPCR method to quantify mRNA transcripts"
Poster Presenter: Nan Jia (WuXi AppTec, Shanghai, Other/None, China)
Co-Authors: Nan Jia, Zhihua Fang, Dan Wang, Jianbo Diao, Jing Shi
Bioanalytical Service, Laboratory Testing Division, WuXi AppTec (Shanghai)
Day2-P18: "Considerations for fit-for-purpose validation of a dendritic cell:CD4+ T cell co-culture assay for evaluating immunogenicity risk of peptide-based impurities."
Poster Presenter: Andrew Graves (Teva Pharmaceuticals, West Chester, Pennsylvania, United States)
Co-Authors: Andrew Graves, Weimin Kong, Giao Pham, Samantha Schultz, and Michele Rasamoelisolo
Specialty Bioanalytics, Teva Pharmaceuticals
Posters on Main Workshop Day3 (Thursday September 29, 2022)

Cytometry and Mass Spectrometry

Day3-P01: "Qualification of a Machine Learning Approach for the Analysis of High-Dimension Immune-Profiling Data in Celiac Disease"
Poster Presenter: William McAuliffe (Takeda Development Center Americas, Inc., Cambridge, Massachusetts, United States)
Co-Authors: 1. William J. McAuliffe 2. Michael T. Boyne II 3. Adam Elhofy 4. Glennda Smithson
1. Takeda Development Center Americas, Inc., Cambridge, MA, USA. 2. COUR Pharmaceuticals Development Co., Inc. Skokie, IL, USA. 3. COUR Pharmaceuticals Development Co., Inc. Skokie, IL, USA. 4. Takeda Development Center Americas, Inc., Cambridge, MA, USA.
Day3-P02: "Development and validation of an 18-markers immunophenotyping panel to support immunotoxicology studies in the non-human primate (NHP) "
Poster Presenter: Elia Henry (Charles River Laboratories, Saint-Germain-Nuelles, Other/None, France)
Co-Authors: DELLUC Stéphanie, CONDEVAUX Fabienne, PONTET Flavien, HENRY Elia, DE LARICHAUDY Joffrey
Charles River Laboratories Lyon, CRL Lyon, 329 Impasse du Domaine Rozier, Domaine des Oncins 69210 Saint-Germain-Nuelles, France
Day3-P03: "A Novel Method for Performing Linearity Assessments in Whole Blood Prepared Using a Lyse/No Wash Procedure"
Poster Presenter: Danielle Salha (Altasciences, Laval, Quebec, Canada)
Co-Authors: Sophie Corbeil, Yun Hui, Deema Khalil, Matthew Woo, Islam Belaid, Martin Poirier, Danielle Salha
Altasciences, Laval, QC, Canada
Day3-P04: "Development of a Surrogate Cerebrospinal Fluid Matrix for Quantitative Analysis of Antisense Oligonucleotides by Hybridization LC-MS/MS"
Poster Presenter: Kevork Mekhssian (Altasciences, Laval, Quebec, Canada)
Co-Authors: Jean-François Dupuis¹, Pei Li², Long Yuan², Kevork Mekhssian¹, and Anahita Keyhani¹
¹Altasciences, Laval, QC; ²Biogen, Cambridge, MA
Day3-P05: "Case Study: A Fast, Novel Strategy to Select an Internal Standard When Developing an Oligonucleotide LC-MS Quantification Method "
Poster Presenter: Zhe Xu (Alliance Pharma, Malvern, Pennsylvania, United States)
Co-Authors: Zhe Xu, John Griffith, and Aihua Liu
Alliance Pharma, Inc., Malvern, PA, USA
Day3-P06: "Cross functional collaboration and an orthogonal approach to the development and validation of bioanalytical methods to measure serum/plasma FGL1 in cancer patients"
Poster Presenter: Jennifer Postelnek (Bristol Myers Squibb, Monroe Township, New Jersey, United States)
Co-Authors: Kristin Taylor, Naiyu Zheng, Shannon Chilewski, Yulia Kim, Tracy Tang, Jianing Zeng, Charlie Garnett-Benson and LaKenya Williams
Bristol Myers Squibb
Day3-P07: "An integrated bioanalytical approach to support antibody-drug conjugate (ADC) platform development"
Poster Presenter: Casey Daniels (AstraZeneca, Gaithersburg, Maryland, United States)
Co-Authors: Moo-jin Suh, Josh Powers, Yuling Wu
AstraZeneca
Day3-P08: "A Novel Hybrid LBA-micro-flow LC-MS/MS assay for PK Bioanalysis of ADCs"
Poster Presenter: Moo-jin Suh (AstraZeneca, Gaithersburg, Maryland, United States)
Co-Authors: Josh Powers, Casey Daniels, Yuling Wu
AstraZeneca, Gaithersburg, MD 20878, United States
Day3-P09: "A multiplexed LC-HRMS method development approach for simultaneous qualitative and quantitative bottom-up protein measurements"
Poster Presenter: Jingjing Fu (Q Squared Solutions, Ithaca, New York, United States)
Co-Authors: Jingjing Fu1, Adriane Spytko1, Kevin Cook2, Michael M. Rosenblatt2, Barry Jones1
1. Q Squared Solutions, Ithaca, NY 2. Promega Corporation, Madison, WI
Day3-P10: "Novel Strategies for Selecting the Right Internal Standard for Hybrid LCMS Bioanalysis of ADC"
Poster Presenter: Yuting Wang (AbbVie, Worcester, Massachusetts, United States)
Co-Authors: Shuai Niu, Vikram Shenoy, Junli Ma, Yihan Li, Hetal Sarvaiya
DMPK-BA, AbbVie Inc
Day3-P11: "Ultrasensitive Quantitation of Intact Endogenous Atrial Natriuretic Peptide in Human Plasma using Multi-Dimensional Nano-LC and High-Resolution Mass Spectrometry"
Poster Presenter: Lian Shan (Q Squared Solutions, Ithaca, New York, United States)
Co-Authors: Stephane Charmont2, Arvind Kinhikar2, and Barry Jones1
1) Q Squared Solutions, 2) Novartis Pharma AG, Basel Switzerland
Day3-P12: "A Sensitive Antibody-free LC-MS Assay to Quantify Human α-L-Iduronidase (hIDUA) in Monkey Serum in the Presence of anti-Drug Antibody and Endogenous Enzyme "
Poster Presenter: John Chen (NovaBioAssays, Cambridge, Massachusetts, United States)
Co-Authors: Drew Tietz, Jiang Wu, Sarah Yuan (Sigilon Tx); Wenchu Yang, John Chen, Chengjie Ji (NovaBioAssays)
Sigilon Therapeutics, NovaBioAssays
Day3-P13: "Selective, Sensitive, and Simultaneous Quantification of Multiple Coagulation Factor VIII (FVIII) Drug Products Present in Human Plasma by LC-MS/MS "
Poster Presenter: Drew Tietz (Sigilon TX, Cambridge, Massachusetts, United States)
Co-Authors: Drew Tietz, Jiang Wu
Sigilon Therapeutics
Day3-P14: "A Robust, Simple, High-Throughput UPLC-MS/MS Assay to Quantify a Novel Biomarker, Phenylacetylglutamine, in Human Plasma"
Poster Presenter: Yu Yang (Alliance Pharma, Malvern, Pennsylvania, United States)
Co-Authors: Yu Yang1; Huiyu Zhou2; Muyang Li1; Baichen Zhang1; Aihua Liu1
1 Alliance Pharma, Malvern, PA, USA 2 Biomarin Pharmaceutical Inc., San Rafael, CA, USA
Day3-P15: "A Novel, Sensitive and High-throughput Assay to Simultaneously Quantify Three Neurotransmitter Biomarkers in Human Plasma by Benzoyl Chloride Derivatization coupled with UPLC-MS/MS"
Poster Presenter: Aihua Liu (Alliance Pharma, Malvern, Pennsylvania, United States)
Co-Authors: Muyang Li1; Huiyu Zhou2; Baichen Zhang1; Yu Yang1; Breanna Harabalya1, Aihua Liu1
1 Alliance Pharma, Malvern, PA; 2 Biomarin Pharmaceutical Inc., San Rafael, CA
Day3-P16: "Comparison of three parallelism assessment methods in biomarker and endogenous analyte quantification by LC-MS/MS"
Poster Presenter: Iris Qiu (Abbvie, North Chicago, Illinois, United States)
Co-Authors: Mei Feng, Kenneth J. Ruterbories, Yueting Wang, John Paul Savaryn, Qin Ji, Gary Jenkins
AbbVie Inc., DMPK-BA, North Chicago, IL 60064
Day3-P17: "Towards a best practice guidance for bioanalytical support of clinical trials in China"
Poster Presenter: Katja Heinig (F. Hoffmann-La Roche, Basel, Other/None, Switzerland)
Co-Authors: Elke Zwanziger, Nicole Justies, Matthew Barfield
F. Hoffmann-La Roche
Day3-P18: "Application of MRM3 in Small Molecule Bioanalysis with Increased Specificity"
Poster Presenter: Brian Dean (Genentech, South San Francisco, California, United States)
Co-Authors: Yusi Cui, Xing (Nancy) Zhang, Stephanie Dale, Yuzhong (Alan) Deng, Brian Dean, Shaokun Pang
Drug Metabolism and Pharmacokinetics, Genentech, Inc., California, 94080 Sciex, Redwood City, California, 94065


For Poster Presenters:

  • Mandatory Presenting Time:
    • During both Morning Break and Afternoon Break of the Day of your Poster - at your poster to answer questions
  • Mount Time:
    • Tue-Thu: 7am to 7:30am
  • Take-down Time:
    • Tue-Wed: 5:30pm to 6:30pm
    • Thu: 4:20pm right after the Afternoon Break

Note: Removing your poster before the take-down time is NOT permitted



Poster Award:

There is poster contest at WRIB each year. Presenters of 3 most outstanding posters will each recieve free registration for next WRIB Main Workshop, as well as an interview by Bioanalysis Journal team, and appearing in a speical feature report in the Bioanalysis Journal and on Bioanalysis Zone.



Poster Board Size:

The size of our poster boards is 8'X4' (8 feet wide and 4 feet high) - standard size as the ones used at most other conferences





Agenda at a Glance Agenda at a Glance